SIOG 2024: Updates in medical oncology
Dr Gunnar Folprecht talks with ecancer at the 2012 ESMO meeting about treating liver metastases in colorectal cancer.
In recent years, oncologists learned that patients who are non-resective could become resective after chemotherapy, thus allowing for increased long-term survival and even cure by removing metastases through surgery.
The challenges now are finding the optimal treatment for shrinking of liver metastasis and learning which patients will benefit the most from this. In addition, there is a need for multidisciplinary cooperation to implement more surgery in patients with liver metastasis.
Filming supported by Amgen
SIOG 2024: Updates in medical oncology
Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Multiple Myeloma: evolving paradigm - Panel Discussion
Advancements in paediatric Acute lymphoblastic leukemia management
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients
Choosing the right patients for transplant
Psychological issues in familial cancer
Multiple myeloma In Rwanda: The need for further research